LAS VEGAS, March 21, 2018 /PRNewswire/ --

FN Media Group Presents Microcapspeculators.com News Commentary 

Virginia Governor Ralph Northam approved a CBD legislation bill to expand the state's medical marijuana program. The Virginia House and Senate passed the bill last month before sending it to Northam for his signature. The Senate's version passed with a unanimous vote February 5. Included in today's commentary: NightFood Holdings, Inc. (OTC: NGTF), INSYS Therapeutics, Inc. (NASDAQ: INSY), Terra Tech Corp. (OTC: TRTC), General Cannabis Corp. (OTC: CANN), and Medical Marijuana, Inc. (OTC: MJNA)

Cannabis activists in the state reacted positively to the news. Not only activists are seeking medical marijuana policy reform in Virginia. Public opinion also favors change. A poll released last year by Quinnipiac University found that 94 percent of Virginians approved of the medicinal use of cannabis. Allowing recreational use of marijuana was supported by 59 percent of those polled.  

This opinion seems to be mirrored nationwide, and is a sentiment that continues to grow.

One reason for this increasing sentiment is the fact many see CBD as an alternative to opioids, which have ravaged American communities with their addictive properties.

In other CBD news includes the following companies: NightFood Holdings, Inc. (OTC: NGTF), INSYS Therapeutics, Inc. (NASDAQ: INSY), Terra Tech Corp. (OTCQX: TRTC), General Cannabis Corp. (OTCQB: CANN), and Medical Marijuana, Inc. (OTC: MJNA).

NightFood Holdings, Inc. (OTC: NGTF)

Market Cap: $13.96M, current share price: $.362 

NGTF the category leading, better-for-you, sleep-friendly nighttime snack company, today announced that the Company has completed its largest production run of NightFood nutrition bars to date.

Over $400,000 worth of product at retail value was produced last week, and delivered to the NightFood fulfillment center on Monday, March 5. All retail back-orders have now been fulfilled, and inventory is currently on the way to Amazon distribution centers across the country.  

MJ Munchies, Inc. was recently formed as a new, wholly owned subsidiary, to exploit legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the brand name "Half-Baked".

GW Pharmaceuticals plc (NASDAQ: GWPH)

Market Cap: $3.38B, current share price: $121.99 

GWPH, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, today announced receipt of Notices of Allowance for five new Epidiolex® patent applications that will be listed in the Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the Orange Book) if the NDA for Epidiolex is approved. Once issued, these patents are set to expire in 2035. One or more patents may be eligible for additional patent term through patent term adjustment and/or regulatory exclusivities.

INSYS Therapeutics, Inc. (NASDAQ: INSY)

Market Cap: $522.01M, current share price: $7.12 

INSY last week reported a loss of $47 million in its fourth quarter. On a per-share basis, the Chandler, Arizona-based company said it had a loss of 65 cents. Losses, adjusted for pre tax expenses and stock option expense, were 20 cents per share.

The specialty pharmaceutical company posted revenue of $31.5 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $32.3 million.

Terra Tech Corp. (OTCQX: TRTC)

Market Cap: $259.38M, current share price: $.268 

TRTC, a vertically integrated cannabis-focused agriculture company, today provided a business update for 2018. These topics will be discussed in more detail on the Company's earnings call this Thursday, March 15th, details of which can be found on the Company's website.

General Cannabis Corp. (OTCQB: CANN)

Market Cap: $118.96M, current share price: $3.54 

CANN, the comprehensive national resource to the regulated cannabis industry, this week announced financial results for the year ended December 31, 2017. "Along with growth through acquisitions, we are also focused on organic growth and driving each segment to profitability," said Joe Hodas, Chief Operating Officer of General Cannabis. "I have spent extensive time with each of our segment leaders, diving into staffing models, revenue projections and challenges. With initial analyses in hand and the existing General Cannabis infrastructure, I believe we can capitalize on new lines of business, cross-sale opportunities between segments, and operating efficiencies. I am eager to work with the great team in place here at General Cannabis to drive strong top line and bottom line results."

Medical Marijuana, Inc. (OTC: MJNA)

Market Cap: $336.47, current share price: $.105 

MJNA, the first publicly traded cannabis company in the United States, just announced that its subsidiary HempMeds® Brazil, which was the first company authorized by Anvisa to import a cannabidiol-based product to Brazil, is partnering with the National Association of Cannabidiol Users (ANUC) to host the Cannabidiol (CBD) Symposium from March 19-23 in Rio Grande do Sul, in the cities of Canoas, Passo Fundo and Porto Alegre. It is the first time that hospitals in Brazil have ever offered cannabis events to the medical community.

For Full Legal Disclaimer Click Here.

DISCLAIMER: Microcapspeculators.com (MS) is the source of the content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM,) and its online brand FinancialNewsMedia.com, is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MS or any company mentioned herein. The commentary, views and opinions expressed in this release by MS are solely those of MS and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MS and FNM for any investment decisions by their readers or subscribers. MS and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks included herein by MS. FNM was not compensated by any public company mentioned herein to disseminate this press release on behalf of MS.

MS Disclosure: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC. which owns Microcapspeculators.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC. which owns, Microcapspeculators.com may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC. this owns Microcapspeculators.com may be compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MS and FNM undertake no obligation to update such statements.

Content Provided By: Microcap Speculators
Email: info@microcapspecualtors.com
Phone: +1-702-720-6310
Website: http://microcapspeculators.com/

Media Contact
FN Media Group LLC
e-mail: editor@financialnewsmedia.com  
+1-(954)345-0611

SOURCE Microcapspeculators.com